My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Merck & Co (NY:MRK)

100.69 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9

...

98 99 Next >

Merck & Co. Inc. (NYSE:MRK) Stands Out as a Durable Dividend Stock ↗

Today 8:41 EST

Merck (MRK) offers a strong 3.43% dividend yield, backed by a history of increases, high profitability, and solid financial health for durable income.

Via Chartmill

AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report ↗

Today 6:52 EST

This comes after President Donald Trump urged drugmakers in July to lower drug prices for the U.S. government’s Medicaid program.

Via Stocktwits

Topics Economy Government

This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026 ↗

Today 3:41 EST

This top-shelf exchange-traded fund (ETF) checks all the right boxes for income- and value-seeking investors.

Via The Motley Fool

Topics Artificial Intelligence ETFs Economy

The 2022 Playbook Returns: Why Investors are Building a 'Fortress 2026'

December 18, 2025

As the calendar turns toward 2026, the exuberant "AI-everything" rally that defined much of 2024 and 2025 is facing a sobering reality check. With the Federal Reserve entering a delicate transition...

Via MarketMinute

Topics Artificial Intelligence Economy World Trade

Merck Scores FDA Fast-Track Review For Key Cholesterol And Cancer Drugs With Multibillion-Dollar Potential: Report ↗

December 17, 2025

While one of the drugs reportedly slated for fast-track review is the cholesterol pill Enlicitide decanoate, the other is its cancer therapy Sacituzumab tirumotecan.

Via Stocktwits

Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗

December 17, 2025

The potential agreements would mark another step in Washington’s broader effort to reshape drug pricing.

Via Stocktwits

Topics Government World Trade

The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now ↗

December 17, 2025

It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive industry.

Via The Motley Fool

Topics Intellectual Property

Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast ↗

December 16, 2025

Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to deliver.

Via The Motley Fool

Topics Intellectual Property Stocks

Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector

December 16, 2025

New York, NY – December 16, 2025 – Pfizer Inc. (NYSE: PFE) today delivered a sobering financial outlook for 2026, projecting revenue and adjusted earnings per share (EPS) that fell short of Wall...

Via MarketMinute

Topics Intellectual Property

Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026? ↗

December 16, 2025

Each company has a bullish case, but three stand out as great long-term buys.

Via The Motley Fool

Topics Bonds Economy Intellectual Property

These S&P500 stocks are gapping in today's session ↗

December 16, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

7 Dividend ETFs to Buy With $2,000 and Hold Forever -- Including the Schwab U.S. Dividend Equity ETF (SCHD) ↗

December 15, 2025

It's hard to beat dividend-paying stocks -- in part because they tend to increase their payouts regularly.

Via The Motley Fool

Topics ETFs

Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? ↗

December 14, 2025

Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Via The Motley Fool

Topics Intellectual Property

Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 ↗

December 12, 2025

They could grow into their valuation over the next few years.

Via The Motley Fool

Topics Intellectual Property

Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles

December 12, 2025

As of December 12, 2025, the financial markets are witnessing a significant "Great Rotation," a pronounced shift of capital from high-growth technology and Artificial Intelligence (AI) stocks to more...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

The Green Revolution in Silicon: Semiconductor Manufacturing Embraces Sustainability

December 12, 2025

The semiconductor industry, the foundational bedrock of our digital world and the engine powering the explosive growth of artificial intelligence, is undergoing a profound transformation. Driven by...

Via TokenRing AI

Topics Artificial Intelligence Climate Change Economy

2 Mega-Cap Stocks with Exciting Potential and 1 We Ignore

December 11, 2025

Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing...

Via StockStory

Dividend Stocks for 2026: Where to Invest as the Market Cools ↗

December 10, 2025

Via MarketBeat

2 Pharmaceutical Stocks to Buy at a Discount ↗

December 10, 2025

Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.

Via The Motley Fool

Topics Intellectual Property

Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution

December 09, 2025

New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index...

Via MarketMinute

Topics ETFs Economy Intellectual Property

Explore the top gainers and losers within the S&P500 index in today's session. ↗

December 09, 2025

Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.

Via Chartmill

Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump ↗

December 09, 2025

The company is finding ways to overcome the headwinds it will encounter in the medium term.

Via The Motley Fool

1 Major Factor Behind the Healthcare Sector's Recent Surge ↗

December 09, 2025

Blockbuster drugs are a major driver of the growth of healthcare stocks.

Via The Motley Fool

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

December 07, 2025

With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them.

Via The Motley Fool

Topics Economy Stocks

Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy? ↗

December 07, 2025

After a long hiatus, why are the bulls so willing to buy in now?

Via The Motley Fool

Topics Intellectual Property

Do These 3 Healthcare Stocks Need a Checkup? ↗

December 05, 2025

These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk?

Via The Motley Fool

Topics Intellectual Property

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? ↗

December 05, 2025

The healthcare stock could skyrocket if ivonescimab obtains approval from regulators, but there's still plenty of risk here.

Via The Motley Fool

Is This Pharmaceutical Giant a Buy After a Major Acquisition? ↗

December 05, 2025

The rebound is well underway.

Via The Motley Fool

Topics Death

These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? ↗

December 05, 2025

After tepid performances throughout most of 2025, these stocks are showing some upward momentum.

Via The Motley Fool

Topics Stocks

With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026 ↗

December 05, 2025

Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new year.

Via The Motley Fool

Topics Artificial Intelligence Economy Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

98 99 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.